Dr. Amir Hossein Hossein Gougol, MD

Dr. Gougol practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Gougol's NPI, 1568810984, was assigned on May 26, 2016. Dr. Gougol graduated from Tehran University of Medical Sciences School of Medicine in 2011. Dr. Gougol holds California license A177795.

Dr. Gougol's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Gougol's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Gougol is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Gougol to 1 more hospital and 1 medical group, each named with a free account. Dr. Gougol's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gougol practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gougol's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gougol is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gougol's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists cirrhosis of the liver among the conditions Dr. Gougol treats.

CMS data shows 547 Medicare services from Dr. Gougol across 11 procedure codes in 2024, for 274 Medicare patients. Medicare paid $59,743 for them.

CMS counts 274 Medicare patients who saw Dr. Gougol in 2024. The largest group is 65 to 74, with 146 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 37% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gougol's median patient age at 55, with 51% women.

In 2024, Dr. Gougol wrote 348 Medicare Part D claims for 124 patients. 78% of them were for generic drugs. CMS names the drug for 231 of them, across 10 drugs with 11 or more claims each, at $97,915 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gougol for performance year 2024, reported as part of a group. Dr. Gougol accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gougol as offering telehealth. CMS counts 39 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gougol, more than 59% of the clinicians it reports for that procedure.

CMS Open Payments shows 4 general payments to Dr. Gougol from 2 drug and device companies from 2021 to 2024. Speaker and faculty fees make up the largest share, 93% of the total. Madrigal Pharmaceuticals paid the most, $2,988.

Dr. Gougol graduated from Tehran University of Medical Sciences School of Medicine in 2011.

Dr. Gougol is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.